Vascular Dementia - Market Insights, Epidemiology and Market Forecast - 2025

Publisher Name :
Date: 28-Jul-2017
No. of pages: 70
Delivery of the Report will take 2-3 working days once order is placed.

DelveInsight's "Vascular Dementia - Market Insights, Epidemiology and Market Forecast - 2025" report provides an overview of the disease and in depth research related to Vascular Dementia for the 7MM (United States, Germany, France, Italy, Spain and UK) for the study period undertaken from 2015-2025. This report provides understanding of the patients affected, diagnosed patterns, treatment trends, unmet medical needs and current developments for Vascular Dementia . It enables understanding of the historical and forecasted epidemiological data for the diagnosed prevalent cases of Vascular Dementia for 7 major markets.

The market outlook also provides understanding of country specific revenue and share by analyzing performance of the current therapies and thorough potential uptake of new products. Additionally, the Report highlights the frontrunners, the drivers and barriers for the Vascular Dementia market, as well as treatment algorithm, current treatments & advancements are included.The chapters including marketed products highlights the advantages and disadvantages associated with therapies associated with Vascular Dementia , providing an in-depth analysis of emerging therapies which will create an impact through their launch.

According to DelveInsight, the forecasted patient population of Vascular Dementia for the year 2025 will be XX, increasing at a CAGR of XX% from 2015 to 2025 and the Vascular Dementia 7MM market size is estimated to be USD XX by 2025.The DelveInsight Report will help in enhanced understanding of the Vascular Dementia market from inside out, with transparency into the calculated patient forecasting data and estimated market size.

Key Coverage

  • Understanding historical and forecasted epidemiological data for Vascular Dementia covering 7MM from 2015-2025.

  • Segment level epidemiology and market split for Vascular Dementia .

  • The thorough assessment of competitors, market, current trends & treatments along with upcoming treatments for Vascular Dementia .

  • The Report also covers the market size for 7MM (United States, EU 5 (Germany, Spain, Italy, France and United Kingdom) and Japan) from 2015-2025 and detailed historical and forecasted Vascular Dementia market trends.

  • Thorough market distribution based on market share for Vascular Dementia .

Reasons to buy

  • The report will help in developing business strategies by understanding trends shaping and driving the Vascular Dementia market.

  • To understand the future market competition in the Vascular Dementia market and Insightful review of the key market drivers and barriers.

  • Organize sales and marketing efforts by identifying the best opportunities for Vascular Dementia in US, Europe (Germany, Spain, Italy, France and United Kingdom) and Japan.

  • Identification of strong upcoming players in market will help in devising strategies that will help in getting ahead of competitors.

Vascular Dementia - Market Insights, Epidemiology and Market Forecast - 2025

Table of Contents

1. Report Introduction

2. Vascular Dementia Market Overview at a Glance
2.1. Total Market Share Distribution of Vascular Dementia for 7 MM in 2016
2.2. Total Market Share Distribution of Vascular Dementia for 7 MM in 2025

3. Vascular Dementia
3.1.1. Overview
3.1.2. Symptoms
3.1.3. Pathophysiology
3.1.4. Staging
3.1.5. Diagnosis
3.1.6. Treatment

4. Epidemiology and Patient Population
4.1.1. United States
4.1.1.1. Diagnosed Cases of Vascular Dementia in United States
4.1.2. Germany
4.1.2.1. Diagnosed Cases of Vascular Dementia in Germany
4.1.3. France
4.1.3.1. Diagnosed Cases of Vascular Dementia in France
4.1.4. Italy
4.1.4.1. Diagnosed Cases of Vascular Dementia in Italy
4.1.5. Spain
4.1.5.1. Diagnosed Cases of Vascular Dementia in Spain
4.1.6. United Kingdom
4.1.6.1. Diagnosed Cases of Vascular Dementia in United Kingdom

5. Treatment Algorithm
5.1.1. Treatment Guidelines/Practices

6. Marketed Drugs for Vascular Dementia
6.1. Drug 1: Company A
6.1.1. Drug Description
6.1.2. Mechanism of Action
6.1.3. Regulatory Milestones
6.1.4. Advantages & Disadvantages
6.1.5. Safety and Efficacy
6.1.6. Product Profile
6.1.7. Patent Status
6.2. Drug 2: Company B
6.2.1. Drug Description
6.2.2. Mechanism of Action
6.2.3. Regulatory Milestones
6.2.4. Advantages & Disadvantages
6.2.5. Safety and Efficacy
6.2.6. Product Profile
6.2.7. Patent Status

7. Emerging Therapies
7.1. Drug 3: Company C
7.1.1. Description
7.1.2. Regulatory Milestones
7.1.3. Advantages & Disadvantages
7.1.4. Product Profile
7.1.5. Launch Date
7.1.6. Clinical Development
7.1.7. Clinical Pipeline Activity
7.1.8. Ongoing Trials Information
7.1.9. Clinical Trial by Phase
7.2. Drug 4: Company B
7.2.1. Description
7.2.2. Regulatory Milestones
7.2.3. Advantages & Disadvantages
7.2.4. Product Profile
7.2.5. Launch Date
7.2.6. Clinical Development
7.2.7. Clinical Pipeline Activity
7.2.8. Ongoing Trials Information
7.2.9. Clinical Trial by Phase

8. Overview of Total Vascular Dementia Market (2016 & 2025)

9. Vascular Dementia : Country-Wise Market Analysis
9.1. United States
9.1.1. Historical Market Size (2015-2016)
9.1.2. Forecasted Market Size (2017-2025)
9.2. Germany Market Size
9.2.1. Historical Market Size (2015-2016)
9.2.2. Forecasted Market Size (2017-2025)
9.3. France Market Size
9.3.1. Historical Market Size (2015-2016)
9.3.2. Forecasted Market Size (2017-2025)
9.4. United Kingdom Market Size
9.4.1. Historical Market Size (2015-2016)
9.4.2. Forecasted Market Size (2017-2025)
9.5. Spain Market Size
9.5.1. Historical Market Size (2015-2016)
9.5.2. Forecasted Market Size (2017-2025)
9.6. Italy Market Size
9.6.1. Historical Market Size (2015-2016)
9.6.2. Forecasted Market Size (2017-2025)
9.7. Japan Market Size
9.7.1. Historical Market Size (2015-2016)
9.7.2. Forecasted Market Size (2017-2025)

10. Market Drivers

11. Market Restraints

12. Appendix

13. Report Methodology

14. Consulting Services

15. Disclaimer

16. About DelveInsight

List of Tables

Table 1: Diagnosed Cases Vascular Dementia in United States (2015-2025)
Table 2: Diagnosed Cases Vascular Dementia in Germany (2015-2025)
Table 3: Diagnosed Cases Vascular Dementia in France (2015-2025)
Table 4: Diagnosed Cases Vascular Dementia in United Kingdom (2015-2025)
Table 5: Diagnosed Cases Vascular Dementia in Spain (2015-2025)
Table 6: Diagnosed Cases Vascular Dementia in Italy (2015-2025)
Table 7: Diagnosed Cases Vascular Dementia in Japan (2015-2025)
Table 8: List of Marketed Drugs for Vascular Dementia
Table 9: List of Pipeline Phase III Drugs for Vascular Dementia
Table 10: Drug 1, Clinical Trials by Zone, 2017
Table 11: Clinical Trials by Trial status, 2017
Table 12: Drug 2, Clinical Trials by Zone, 2017
Table 13: Clinical Trials by Trial status, 2017
Table 14: Drug 3, Clinical Trials by Zone, 2017
Table 15: Clinical Trials by Trial status, 2017
Table 16: United States Market Size of Vascular Dementia in USD, Million (2015-2025)
Table 17: Germany Market Size of Vascular Dementia in USD, Million (2015-2025)
Table 18: France Market Size of Vascular Dementia in USD, Million (2015-2025)
Table 19: United Kingdom Market Size of Vascular Dementia in USD, Million (2015-2025)
Table 20: Spain Market Size of Vascular Dementia in USD, Million (2015-2025)
Table 21: Italy Market Size of Vascular Dementia in USD, Million (2015-2025)
Table 22: Japan Market Size of Vascular Dementia in USD, Million (2015-2025)

List of Figures

Figure 1: Diagnosed Cases Vascular Dementia in United States (2015-2025)
Figure 2: Diagnosed Cases Vascular Dementia in Germany (2015-2025)
Figure 3: Diagnosed Cases Vascular Dementia in France (2015-2025)
Figure 4: Diagnosed Cases Vascular Dementia in United Kingdom (2015-2025)
Figure 5: Diagnosed Cases Vascular Dementia in Spain (2015-2025)
Figure 6: Diagnosed Cases Vascular Dementia in Italy (2015-2025)
Figure 7: Diagnosed Cases Vascular Dementia in Japan (2015-2025)
Figure 8: List of Marketed Drugs for Vascular Dementia
Figure 9: List of Pipeline Phase III Drugs for Vascular Dementia
Figure 10: Drug 1, Clinical Trials by Zone (%), 2017
Figure 11: Clinical Trials by Trial status, 2017
Figure 12: Drug 2, Clinical Trials by Zone (%), 2017
Figure 13: Clinical Trials by Trial status, 2017
Figure 14: Drug 3, Clinical Trials by Zone (%), 2017
Figure 15: Clinical Trials by Trial status, 2017
Figure 16: United States Market Size of Vascular Dementia in USD, Million (2015-2025)
Figure 17: Germany Market Size of Vascular Dementia in USD, Million (2015-2025)
Figure 18: France Market Size of Vascular Dementia in USD, Million (2015-2025)
Figure 19: United Kingdom Market Size of Vascular Dementia in USD, Million (2015-2025)
Figure 20: Spain Market Size of Vascular Dementia in USD, Million (2015-2025)
Figure 21: Italy Market Size of Vascular Dementia in USD, Million (2015-2025)
Figure 22: Japan Market Size of Vascular Dementia in USD, Million (2015-2025)
  • Dementia - Pipeline Review, H2 2017
    Published: 16-Aug-2017        Price: US 2000 Onwards        Pages: 243
    Dementia - Pipeline Review, H2 2017 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Dementia - Pipeline Review, H2 2017, provides an overview of the Dementia (Central Nervous System) pipeline landscape. Dementia is the loss of mental functions such as thinking, memory, and reasoning that is severe enough to interfere with a person's daily functioning. Symptoms include memory loss, hallucinations, agitation, pe......
  • Global Alzheimer's Drugs Market Research Report 2017
    Published: 16-Aug-2017        Price: US 2900 Onwards        Pages: 104
    In this report, the global Alzheimer's Drugs market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report is segmented into several key Regions, with production, consumption, revenue (million USD), market share and growth rate of Alzheimer's Drugs in these regions, from 2012 to 2022 (forecast), covering - North America - Europe - China -......
  • United States Alzheimer's Drugs Market Report 2017
    Published: 09-Aug-2017        Price: US 3800 Onwards        Pages: 103
    In this report, the United States Alzheimer's Drugs market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report splits the United States market into seven regions: - The West - Southwest - The Middle Atlantic - New England - The South - The Midwest with sales (volume), revenue (value), market share and growth rate o......
  • Global Alzheimer's Drugs Sales Market Report 2017
    Published: 02-Aug-2017        Price: US 4000 Onwards        Pages: 105
    In this report, the global Alzheimer's Drugs market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report split global into several key Regions, with sales (K Pcs), revenue (Million USD), market share and growth rate of Alzheimer's Drugs for these regions, from 2012 to 2022 (forecast), covering - United States - China - Europe - Japan......
  • Europe Alzheimer's Disease Drug Market by Manufacturers, Countries, Type and Application, Forecast to 2022
    Published: 01-Aug-2017        Price: US 4480 Onwards        Pages: 115
    Alzheimer's disease (AD), also referred to simply as Alzheimer's, is a chronic neurodegenerative disease that usually starts slowly and worsens over time. It is the cause of 60% to 70% of cases of dementia.Scope of the Report:This report focuses on the Alzheimer's Disease Drug in Europe market, especially in Germany, UK, France, Russia, and Italy. This report categorizes the market based on manufacturers, countries, type and application.Market Segment by Manufac......
  • Vascular Dementia - Epidemiology Insights to 2025
    Published: 28-Jul-2017        Price: US 2950 Onwards        Pages: 40
    DelveInsight's "Vascular Dementia -Epidemiology Forecast, 2025" provides an overview of the epidemiology trends of Vascular Dementia in seven major markets (US, France, Germany, Italy, Spain, UK and Japan). It includes 10 years epidemiology historical and forecasted data of Vascular Dementia. The Report also discusses the prevailing risk factors, disease burden with special emphasis on the unmet medical needs associated with the Vascular Dementia. The report contains the targeted patient populat......
  • Vascular Dementia - Pipeline Insight, 2017
    Published: 28-Jul-2017        Price: US 1250 Onwards        Pages: 50
    DelveInsight's, "Vascular Dementia-Pipeline Insights, 2017", report provides comprehensive insights of the ongoing therapeutic research and development across Vascular Dementia. The report provides a complete understanding of the pipeline activities covering all clinical, pre-clinical and discovery stage products. A comparative pipeline therapeutics assessment of Vascular Dementia by development stage, therapy type, route of administration and molecule type is also covered in the report. It also......
  • Global Dementia and Movement Disorder Treatment Market 2017-2021
    Published: 19-Jul-2017        Price: US 3500 Onwards        Pages: 102
    Dementia is a collective term for disorders characterized by progressive degeneration of the brain. It impairs memory and affects behavioral, emotional, and cognitive abilities. The neuronal death or neuronal malfunction associated with the disorder manifests as shifts in mood and personality changes, difficulty in performing activities, loss of memory, and aphasia. Dementia can be classified into different types, based on the parts of brain affected. Among these types, Alzheimer's disease is......
  • Global Alzheimer's Drugs Market 2017-2021
    Published: 12-Jul-2017        Price: US 3500 Onwards        Pages: 102
    Alzheimer's disease is a progressive and irreversible degeneration of the brain that disrupts the thinking, language, behavior, and cognitive skills of a person. It is more prevalent in people aged 65 years and above and affects more women than men. As per the Centers for Disease Control and Prevention (CDC), 5.4 million Americans are affected by this disease, and the incidence rate of disease increases with age and doubles every five years for adults beyond 65 years of age. The analy......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - sales@rnrmarketresearch.com / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs